DE2845765A1 - Einfaches glukan - Google Patents

Einfaches glukan

Info

Publication number
DE2845765A1
DE2845765A1 DE19782845765 DE2845765A DE2845765A1 DE 2845765 A1 DE2845765 A1 DE 2845765A1 DE 19782845765 DE19782845765 DE 19782845765 DE 2845765 A DE2845765 A DE 2845765A DE 2845765 A1 DE2845765 A1 DE 2845765A1
Authority
DE
Germany
Prior art keywords
gel
million
bio
measured
gel filtration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19782845765
Other languages
German (de)
English (en)
Inventor
Kazuaki Hama
Hiroyuki Ohno
Yutaro Sasaki
Mamoru Sugiura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE2845765A1 publication Critical patent/DE2845765A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE19782845765 1977-10-24 1978-10-20 Einfaches glukan Withdrawn DE2845765A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12674377A JPS5461112A (en) 1977-10-24 1977-10-24 Oncostatic polysaccharide* its preparation* and oncostatic drugs containing it as an effective component

Publications (1)

Publication Number Publication Date
DE2845765A1 true DE2845765A1 (de) 1979-04-26

Family

ID=14942798

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782845765 Withdrawn DE2845765A1 (de) 1977-10-24 1978-10-20 Einfaches glukan

Country Status (8)

Country Link
US (2) US4237266A (en:Method)
JP (1) JPS5461112A (en:Method)
CA (1) CA1107725A (en:Method)
DE (1) DE2845765A1 (en:Method)
FR (1) FR2406447A1 (en:Method)
GB (1) GB2007246B (en:Method)
HU (1) HU179066B (en:Method)
IT (1) IT1192585B (en:Method)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208057A1 (de) * 1981-03-06 1982-09-16 Takara Shuzo Co., Ltd., Kyoto Ss-1,3-glucan mit hohem molekulargewicht und verfahren zu seiner herstellung
US4629627A (en) * 1978-12-29 1986-12-16 Chiyokichi Iizuka Antiviral substance and the manufacturing method thereof
WO2003097849A1 (en) * 2002-05-22 2003-11-27 The Chinese University Of Hong Kong Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314999A (en) * 1978-07-31 1982-02-09 Proter S.P.A. N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity
JPS5712999A (en) * 1980-06-25 1982-01-22 Chiyokichi Iizuka Antibiral agent and its preparation
US4435389A (en) 1980-07-07 1984-03-06 Kabushiki Kaisha Yakult Honsha Composition for promoting growth of bifidobacteria
DE3071815D1 (en) * 1980-08-05 1986-12-11 Debat Lab Use of glycosylglucanes in the treatment of infections of the large intestines
US4477437A (en) * 1981-02-19 1984-10-16 Toyama Chemical Co., Ltd. Substances having carcinostatic and immunostimulating activity
GB2093347B (en) * 1981-02-19 1985-03-27 Toyama Chemical Co Ltd Immunostimulant material tf-2 from fusobacterium sp
US4417415A (en) * 1982-04-26 1983-11-29 Battelle Development Corporation Process for culturing a microalga, and extracting a polysaccharide therefrom
JPS60255733A (ja) * 1984-05-30 1985-12-17 Nippon Beet Sugar Mfg Co Ltd β−Ｄ−グルカン
US4975421A (en) * 1985-08-19 1990-12-04 Bioglucan, Lp. Soluble phosphorylated glucan: methods and compositions for wound healing
US4900722A (en) * 1985-08-19 1990-02-13 Bioglucans, L.P. Methods and compositions for prophylactic and therapeutic treatment of infections
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
JPH0692441B2 (ja) * 1986-03-03 1994-11-16 株式会社林原生物化学研究所 β−Ｄ−グルカンとその製造方法及び用途
DE3643467A1 (de) * 1986-12-19 1988-06-30 Wintershall Ag Verfahren zur extrazellulaeren herstellung nichtionischer biopolymerer und deren verwendung
JPS63307825A (ja) * 1987-06-08 1988-12-15 Nippon Beet Sugar Mfg Co Ltd 抗腫瘍剤及びその製法
FI885955A7 (fi) * 1987-12-23 1989-06-24 Weston George Ltd Ny b-1,3-glukanexopolysackarid och foerfarande foer framstaellning av densamma.
FR2631829B1 (fr) * 1988-05-30 1992-04-03 Pasteur Institut Exopolysaccharides fongiques ayant une activite immunostimulante, leur procede d'obtention et composition therapeutique les contenant
US4950749A (en) * 1989-01-06 1990-08-21 The Standard Oil Company Recovery of glucan by employing a divalent cation at an alkaline pH
US4960697A (en) * 1989-01-06 1990-10-02 The Standard Oil Company Recovery of polysaccharides by employing a divalent cation with a water miscible organic solvent
US5811542A (en) * 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
CA2066172A1 (en) * 1989-09-08 1991-03-09 Alpha Beta Technology, Inc. Method for producing soluble glucans
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
JPH0784481B2 (ja) * 1991-02-21 1995-09-13 株式会社デイ・デイ・エス研究所 カルボキシメチルマンノグルカン及びその誘導体
US5567812A (en) * 1994-04-15 1996-10-22 The United States Of America, As Represented By The Secretary Of Agriculture Polysaccharide products derived from lesquerella fendleri and methods of their production
DE69531782T2 (de) * 1994-06-30 2004-07-01 Meiji Dairies Corp. Heisswasser-Extrakt von Cordyceps sinensis
US5622940A (en) * 1994-07-14 1997-04-22 Alpha-Beta Technology Inhibition of infection-stimulated oral tissue destruction by β(1,3)-glucan
US5716546A (en) * 1996-10-23 1998-02-10 Osram Sylvania Inc. Reduction of lag in yttrium tantalate x-ray phosphors
US6046323A (en) * 1997-07-29 2000-04-04 The Collaborative Group, Ltd. Conformations of PPG-glucan
US6369216B1 (en) 1998-09-25 2002-04-09 Biopolymer Engineering Pharmaceutical, Inc. Very high molecular weight β-glucans
AU6261999A (en) * 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
CA2438984C (en) 2001-02-28 2009-10-20 Iogen Energy Corporation Method of processing lignocellulosic feedstock for enhanced xylose and ethanol production
CN100471869C (zh) * 2002-05-22 2009-03-25 香港中文大学 制备和检定具有可检验的口服吸收性云芝的免疫调节的肽联葡聚糖
EP1545208A4 (en) * 2002-08-13 2006-04-12 Biopolymer Engineering Inc PROCESS FOR USE OF BETA-GLUCAN AS A RADIATION PROTECTION AGENT
AU2003268486A1 (en) * 2002-09-04 2004-03-29 Biopolymer Engineering, Inc. Cancer therapy using whole glucan particles and antibodies
US20060165700A1 (en) * 2002-09-04 2006-07-27 Ostroff Gary R Cancer therapy using whole glucan particles and antibodies
KR100468649B1 (ko) * 2003-01-29 2005-01-27 학교법인 영광학원 항보체 활성을 갖는 운지버섯 자실체 유래의 다당체 및 그분리방법
US7197521B2 (en) * 2003-11-21 2007-03-27 Intel Corporation Method and system performing concurrently mark-sweep garbage collection invoking garbage collection thread to track and mark live objects in heap block using bit vector
CN101626773B (zh) * 2006-11-02 2013-04-17 奥力有限公司 一种生体治愈促进剂
US20090098619A1 (en) * 2007-10-16 2009-04-16 Shiu Nan Chen Method of producing liquid and powered mushroom beta-glucan
CN109400686A (zh) * 2018-10-23 2019-03-01 西北农林科技大学 一种云芝β-葡聚糖肽的提取方法及其在肥胖或相关疾病中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3301848A (en) * 1962-10-30 1967-01-31 Pillsbury Co Polysaccharides and methods for production thereof
US3856775A (en) * 1969-07-14 1974-12-24 Ajinomoto Kk {62 -(1{43 3)-glucans
JPS5339519B1 (en:Method) * 1970-07-31 1978-10-21
US4051314A (en) * 1970-10-14 1977-09-27 Kureha Kagaku Kogyo Kabushiki Kaisha Polysaccharides and method for producing same
DE2351520C2 (de) * 1972-10-16 1982-10-21 Takeda Chemical Industries, Ltd., Osaka Verfahren zur Konzentrierung von Suspensionen von thermisch gelierbaren Polysacchariden
JPS4993039A (en:Method) * 1972-10-20 1974-09-04
JPS5213443B2 (en:Method) * 1972-11-29 1977-04-14
JPS5136359A (ja) * 1974-09-18 1976-03-27 Saburokichi Tanimoto Kukimatsuto
DE2551438C2 (de) * 1974-11-26 1986-04-03 Takeda Chemical Industries, Ltd., Osaka Verfahren zur Herstellung von β-1,3-Glucanderivaten
JPS5315495A (en) * 1976-07-22 1978-02-13 Kureha Chem Ind Co Ltd Preparation of polysaccharides
JPS5344693A (en) * 1976-10-05 1978-04-21 Hirofumi Takahashi Production of polysaccharide
JPS5394012A (en) * 1977-01-27 1978-08-17 Kureha Chem Ind Co Ltd Novel polysaccharide and its preparation
JPS53134060A (en) * 1977-04-28 1978-11-22 Kaken Pharmaceut Co Ltd Novel polysaccharide

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629627A (en) * 1978-12-29 1986-12-16 Chiyokichi Iizuka Antiviral substance and the manufacturing method thereof
DE3208057A1 (de) * 1981-03-06 1982-09-16 Takara Shuzo Co., Ltd., Kyoto Ss-1,3-glucan mit hohem molekulargewicht und verfahren zu seiner herstellung
WO2003097849A1 (en) * 2002-05-22 2003-11-27 The Chinese University Of Hong Kong Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
GB2407321A (en) * 2002-05-22 2005-04-27 Univ Hong Kong Chinese Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
GB2407321B (en) * 2002-05-22 2006-04-19 Univ Hong Kong Chinese Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor

Also Published As

Publication number Publication date
US4237266A (en) 1980-12-02
FR2406447A1 (fr) 1979-05-18
IT1192585B (it) 1988-04-20
US4225673A (en) 1980-09-30
FR2406447B1 (en:Method) 1983-02-18
CA1107725A (en) 1981-08-25
IT7829043A0 (it) 1978-10-24
HU179066B (en) 1982-08-28
GB2007246A (en) 1979-05-16
GB2007246B (en) 1982-08-18
JPS5461112A (en) 1979-05-17

Similar Documents

Publication Publication Date Title
US4237266A (en) Glucan having antitumor activity
DE69514498T2 (de) Polysaccharide und deren Herstellung
DE3208057C2 (de) ß-1,3-Glucan
DE2050714C2 (de) Polysaccharid mit Antitumoraktivität, Verfahren zu seiner Gewinnung und seine Verwendung als Wirkstoff in Antitumormitteln
DE2441454C3 (de) Antileukämische proteinhaltige Fraktion und ihre Herstellung
DE2655844C3 (de) Verfahren zur Herstellung antitumorwirksamer Substanzen
DE3241990C2 (de) Saures Polysaccharid und Verfahren zu seiner Herstellung
DE2659808C3 (de) Proteingebundene Polysaccharide und deren Verwendung zur Bekämpfung von Tumoren
DE2731570C3 (de) Verfahren zur Gewinnung eines Polysaccharide mit therapeutischer Wirkung
DE69116601T2 (de) Verfahren zur Herstellung von Antitumordextran
DE3032636C2 (en:Method)
US4614733A (en) Polysaccharides pharmaceutical compositions and the use thereof
EP0286869B1 (de) Verfahren zur Herstellung von Zellwandkomponenten aus Halobakterien und deren Verwendung als Arzneimittel
DE3409029C2 (en:Method)
DE3035193A1 (de) Neues antibiotikum sf-1130-x(pfeil abwaerts)3(pfeil abwaerts), verfahren zur herstellung desselben sowie mittel, welche das neue antibiotikum
DE3329255C2 (de) Verfahren zur Herstellung der Substanz TF-500 mit carcinostatischen und immunostimulierenden Eigenschaften
DE2803681C2 (en:Method)
JPS6359679B2 (en:Method)
DE2809092A1 (de) Verfahren zur herstellung von emitanin
US4477437A (en) Substances having carcinostatic and immunostimulating activity
DE2737943A1 (de) Neue antibiotika, substanzen sf-1130- x tief 1 und -x tief 2 , verfahren zu ihrer herstellung und ihre verwendung
DE3147954A1 (de) Hochmolekulares polysaccharid mps-80, verfahren zu dessen herstellung und verwendung desselben
DE3123830A1 (de) "antivirussubstanz und verfahren zu ihrer herstellung"
DE2760203C2 (de) Antibiotisch wirksames Oligosaccharid, Verfahren zu seiner Herstellung sowie dieses enthaltendes Arzneimittel
DE1617868A1 (de) Verfahren zur Herstellung einer anticanceroes wirksamen Substanz

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee